The spread of SARS-CoV-2 and ongoing COVID-19 pandemic underscores the need for new treatments. Here we report that cannabidiol (CBD) inhibits infection of SARS-CoV-2 in cells and mice. CBD and its m
This study aimed to explore the clinical implications and composition of the intestinal microbiota in children following SARS CoV 2 infections in Taiwan. Pediatric patients diagnosed with SARS CoV 2 d
SARS-CoV-2, the agent causing COVID-19, invades epithelial cells, including those of the respiratory and gastrointestinal mucosa, using angiotensin-converting enzyme-2 (ACE2) as a receptor. Subsequent